BRPI0509213A - método para previnir, reduzir ou minimizar a formação de impurezas de tioamida durante a tionação de um composto de carbonila, produto, e, uso de um agente extrator - Google Patents

método para previnir, reduzir ou minimizar a formação de impurezas de tioamida durante a tionação de um composto de carbonila, produto, e, uso de um agente extrator

Info

Publication number
BRPI0509213A
BRPI0509213A BRPI0509213-2A BRPI0509213A BRPI0509213A BR PI0509213 A BRPI0509213 A BR PI0509213A BR PI0509213 A BRPI0509213 A BR PI0509213A BR PI0509213 A BRPI0509213 A BR PI0509213A
Authority
BR
Brazil
Prior art keywords
formation
minimizing
preventing
reducing
product
Prior art date
Application number
BRPI0509213-2A
Other languages
English (en)
Inventor
Bogdan Kazimierz Wilk
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0509213A publication Critical patent/BRPI0509213A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

MéTODO PARA PREVENIR, REDUZIR OU MINIMIZAR A FORMAçãO DE IMPUREZAS DE TIOAMIDA DURANTE A TIONAçãO DE UM COMPOSTO DE CARBONILA, PRODUTO, E, USO DE UM AGENTE EXTRATOR São fornecidos métodos para minimizar a formação de compostos de tioamida com uso de agentes extratores durante reações tais como as tionações de compostos de carbonila contendo grupos de nitrila.
BRPI0509213-2A 2004-04-08 2005-04-07 método para previnir, reduzir ou minimizar a formação de impurezas de tioamida durante a tionação de um composto de carbonila, produto, e, uso de um agente extrator BRPI0509213A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56040304P 2004-04-08 2004-04-08
PCT/US2005/013657 WO2005100347A1 (en) 2004-04-08 2005-04-07 Methods for minimizing thioamide impurities

Publications (1)

Publication Number Publication Date
BRPI0509213A true BRPI0509213A (pt) 2007-08-28

Family

ID=34966434

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509213-2A BRPI0509213A (pt) 2004-04-08 2005-04-07 método para previnir, reduzir ou minimizar a formação de impurezas de tioamida durante a tionação de um composto de carbonila, produto, e, uso de um agente extrator

Country Status (14)

Country Link
US (2) US7314932B2 (pt)
EP (1) EP1732922B1 (pt)
JP (1) JP4950027B2 (pt)
CN (1) CN1938298B (pt)
AT (1) ATE409699T1 (pt)
AU (1) AU2005233648B2 (pt)
BR (1) BRPI0509213A (pt)
CA (1) CA2561313C (pt)
DE (1) DE602005010065D1 (pt)
DK (1) DK1732922T3 (pt)
ES (1) ES2313334T3 (pt)
MX (1) MXPA06011695A (pt)
PL (1) PL1732922T3 (pt)
WO (1) WO2005100347A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4950027B2 (ja) 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
US20090170823A1 (en) * 2007-12-20 2009-07-02 Duramed Pharmaceuticals, Inc. Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308064D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
US4997950A (en) * 1989-04-20 1991-03-05 Richard Finbar Murphy Novel C-terminal gastrin antagonists
JPH0834775A (ja) * 1994-05-16 1996-02-06 Sumitomo Chem Co Ltd テトラゾール化合物の製造法
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
AU767762B2 (en) * 1999-05-04 2003-11-20 Wyeth Thio-oxindole derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
US7132445B2 (en) * 2001-04-16 2006-11-07 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
JP2005535623A (ja) * 2002-06-25 2005-11-24 ワイス ホルモン関連症状の治療における、チオ−オキシインドール誘導体の使用
AU2003247608A1 (en) * 2002-06-25 2004-01-06 Wyeth Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
EP1531824A4 (en) * 2002-06-25 2005-09-21 Wyeth Corp CYCLOTHIOCARBAMATE DERIVATIVES AS PR-MODULATORS AND THEIR USE IN THE TREATMENT OF SKIN DISEASES
MXPA04012418A (es) * 2002-06-25 2005-04-19 Wyeth Corp Uso de derivados de tio-oxindol en tratamiento de trastornos de la piel.
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
JP4950027B2 (ja) 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法

Also Published As

Publication number Publication date
EP1732922A1 (en) 2006-12-20
CN1938298A (zh) 2007-03-28
ATE409699T1 (de) 2008-10-15
US20050228179A1 (en) 2005-10-13
CA2561313A1 (en) 2005-10-27
MXPA06011695A (es) 2006-12-14
ES2313334T3 (es) 2009-03-01
JP2007532581A (ja) 2007-11-15
DK1732922T3 (da) 2009-01-12
DE602005010065D1 (de) 2008-11-13
US20080071083A1 (en) 2008-03-20
US7572824B2 (en) 2009-08-11
JP4950027B2 (ja) 2012-06-13
CN1938298B (zh) 2013-02-06
AU2005233648A1 (en) 2005-10-27
CA2561313C (en) 2012-12-04
AU2005233648B2 (en) 2011-06-23
PL1732922T3 (pl) 2009-03-31
EP1732922B1 (en) 2008-10-01
US7314932B2 (en) 2008-01-01
WO2005100347A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
ATE433447T1 (de) Pyrimiidinverbindungen
MX2009006227A (es) Inhibidores de aspartil proteasa que contienen un sistema de anillo triciclico.
EA200970605A1 (ru) Ингибиторы mapk/erk-киназ
MXPA05009694A (es) Metodos para mejorar la calidad de la piel.
EA201070247A1 (ru) Ингибиторы протеасом
UY33981A (es) ?método para preparar compuestos macrocíclicos inhibidores de serina proteasas de hepatitis c?.
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
CL2007003060A1 (es) Compuestos derivados de piridazina; proceso para la preparacion de dichos compuestos; composicion fungicida para controlar o proteger contra microorganismos fitopatogenicos;uso de dichos compuestos; y metodo para controlar o proteger contra microorganismos fitopatogenicos.
EA200870103A1 (ru) Феноксиуксусные кислоты в качестве активаторов ppar дельта
TW200510317A (en) Caspase inhibitors and uses thereof
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
DE602004024213D1 (en) Aminopropanolderivate
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
DK1539724T3 (da) Aminobenzothiazolforbindelser med NOS-inhiberende aktivitet
DE602005012481D1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
SE0300850D0 (sv) Chemical compounds
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
ATE457982T1 (de) Thiazol-(bi)cycloalkyl-carboxanilide
FR2882751B1 (fr) Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, procede de preparation, compositions les contenant et utilisation
ATE460938T1 (de) Morpholin-derivate zur verwendung als dopaminagonisten in der behandlung von u.a. sexueller dysfunktion
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
MX2009003533A (es) Composición farmacéutica que comprende derivado de fenilamidina y método para usar la composición farmacéutica en combinación con el aceite antifúngico.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: WYETH LLC. (US)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.